Cerenis Therapeutics Holding Stock Euronext Paris
Equities
FR0012616852
Biotechnology & Medical Research
Sales 2023 | 4.6M 4.92M | Sales 2024 * | 4.6M 4.92M | Capitalization | 32.98M 35.28M |
---|---|---|---|---|---|
Net income 2023 | -3M -3.21M | Net income 2024 * | -6M -6.42M | EV / Sales 2023 | 9.02 x |
Net cash position 2023 * | 100K 107K | Net cash position 2024 * | 3.4M 3.64M | EV / Sales 2024 * | 6.43 x |
P/E ratio 2023 * |
-7.31
x | P/E ratio 2024 * |
-6.83
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 77.63% |
Managers | Title | Age | Since |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Director of Finance/CFO | - | 08-04-30 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 15-02-05 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |